HER1-Targeted (86)Y-Panitumumab Possesses Superior Targeting Characteristics than (86)Y-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts

por Nayak, Tapan K., Garmestani, Kayhan, Milenic, Diane E., Baidoo, Kwamena E., Brechbiel, Martin W.
Publicado 2011

In vitro and in vivo pre-clinical analysis of a F(ab')(2 )fragment of panitumumab for molecular imaging and therapy of HER1-positive cancers

por Wong, Karen J, Baidoo, Kwamena E, Nayak, Tapan K, Garmestani, Kayhan, Brechbiel, Martin W, Milenic, Diane E
Publicado 2011